The Cancer Center of Kansas (CCK) has a comprehensive research program offering many opportunities for oncology patients to participate in clinical trials. The oncologists at CCK have always believed their patients should not have to travel hundreds of miles away from loved ones and friends to receive state-of-the-art treatment. This belief led to the development of the first community-based nationally recognized research program in 1983 through the National Cancer Institute (NCI), the Wichita Community Clinical Oncology Program (Wichita CCOP), which later changed its name to Cancer Research of Kansas (CRK).
Through the years the CCK research team and its physicians have remained dedicated in providing the best care available for the treatment and prevention of all cancers and the management and treatment of symptoms and side effects.
CCK works in collaboration with Wichita NCI Community Oncology Program (formerly Wichita CCOP) with offerings from affiliations such as Southwest Oncology Group, Alliance for Clinical Trials in Oncology (Mayo Clinic and Memorial Sloan Kettering), MD Anderson Cancer Center, ECOG-ACRIN Cancer Research Group and University of Rochester Cancer Center (New York).
CCK also partnerships with several pharmaceutical, bio-pharmaceutical, and diagnostic companies in an effort to provide cutting-edge therapeutic options even years prior to being FDA approved.
Several recent approvals of agents used in the oncology arena granted by the FDA were made possible by the efforts of the CCK research team and the many dedicated patients of CCK.
If you are eligible for any of the trials offered by one of our research programs, your CCK physician will discuss these opportunities with you along with other treatment options. Participation in clinical trials is voluntary and requires your informed consent.
If you have any questions regarding your participation in a clinical trial, you should discuss these with your CCK physician. You may also call CCK and ask to speak to a member of the research team.
